|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2008-11-3
|
|
pubmed:abstractText |
Kallikreins are a subgroup of serine proteases with diverse physiologic functions. It has been confirmed that kallikrein 7 (KLK7) is differentially expressed in ovarian and breast cancer. Antileukoprotease (ALP) has been shown to be a specific inhibitor of human kallikrein 7 (hK7). Antileukoprotease overexpression is commonly associated with aggressive, high-risk, or metastatic cancer originating from various organs.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1543-2165
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
132
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1796-801
|
|
pubmed:meshHeading |
pubmed-meshheading:18976018-Adenocarcinoma,
pubmed-meshheading:18976018-Case-Control Studies,
pubmed-meshheading:18976018-Cell Line, Tumor,
pubmed-meshheading:18976018-Down-Regulation,
pubmed-meshheading:18976018-Epithelial Cells,
pubmed-meshheading:18976018-Humans,
pubmed-meshheading:18976018-Kallikreins,
pubmed-meshheading:18976018-Male,
pubmed-meshheading:18976018-Prostate,
pubmed-meshheading:18976018-Prostatic Hyperplasia,
pubmed-meshheading:18976018-Prostatic Neoplasms,
pubmed-meshheading:18976018-RNA, Messenger,
pubmed-meshheading:18976018-Secretory Leukocyte Peptidase Inhibitor
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Expression of the serine protease kallikrein 7 and its inhibitor antileukoprotease is decreased in prostate cancer.
|
|
pubmed:affiliation |
Institute of Urology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
